Cancer Marker Panel (Female)

Our Cancer Marker Panel (Female) is a targeted screening package that helps identify biological signals associated with female-specific cancers, providing women in Dubai with timely information to support proactive health management. The panel is designed to assess areas related to breast and gynecological health by measuring markers that may indicate changes warranting closer monitoring or further clinical evaluation. This service functions as a screening and risk‑assessment tool rather than a definitive diagnostic test, so unexpected results typically lead to additional tests or specialist review. Discussing findings with your healthcare provider ensures appropriate follow-up and a personalised plan based on your individual risk factors and medical history.

• CA-125
• HE4
• CA 15-3
• CA 27.29
• CEA
• CA 19-9
• AFP
• Beta-hCG
• SCC Antigen
• CYFRA 21-1
• NSE

Preparing for your Cancer Marker Panel (Female) is simple and important for accurate results. Here are a few essential preparation tips:

• No fasting is required prior to the test.
• Regular hydration is encouraged; drink plenty of water.
• Continue taking any prescribed medications unless instructed otherwise by your healthcare provider.
• Arrive at the testing center at your scheduled time for a smooth experience.

The Cancer Marker Panel (Female) report provides results for the specific biomarkers included in this screening package and highlights any values that fall outside the laboratory reference ranges to help guide next steps. Results should be interpreted alongside symptoms, medical history, age, gender and other clinical factors, and an abnormal or borderline value does not automatically indicate a disease. A licensed healthcare professional in Dubai can review the report with you and explain what the findings mean for your individual care plan.